Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€346.26
Performance (%)
5.28%
Price
16:17
€295.70
Summary
This prediction is currently active. With a performance of 5.28%, the BUY prediction by The_Goldman_Sachs_Gr for Amgen Inc. is trending in the right direction. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 15.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.624% | 0.624% |
| iShares Core DAX® | -0.201% | 5.471% |
| iShares Nasdaq 100 | 2.573% | 10.092% |
| iShares Nikkei 225® | 0.598% | 9.871% |
| iShares S&P 500 | 1.804% | 7.404% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $400.00 to $403.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat